scispace - formally typeset
Search or ask a question
Institution

Wake Forest University

EducationWinston-Salem, North Carolina, United States
About: Wake Forest University is a education organization based out in Winston-Salem, North Carolina, United States. It is known for research contribution in the topics: Population & Diabetes mellitus. The organization has 21499 authors who have published 48731 publications receiving 2246027 citations. The organization is also known as: Wake Forest College.


Papers
More filters
Journal ArticleDOI
TL;DR: Understanding the acquisition and usage of multisensory integration in the midbrain and cerebral cortex of mammals has been aided by a multiplicity of approaches and some of the challenging questions that remain are examined.
Abstract: Multisensory integration allows information from multiple senses to be combined, with benefits for nervous-system processing. Stein and Stanford discuss the principles of multisensory integration in single neurons in the CNS and consider the questions that the field must address.

1,110 citations

Journal ArticleDOI
01 Jan 2006-Chest
TL;DR: Subgroup analyses suggest the risk may be greater in African Americans compared with Caucasian subjects and whether this risk is due to factors including but not limited to a physiologic treatment effect, genetic factors, or patient behaviors leading to poor outcomes remains unknown.

1,108 citations

Journal ArticleDOI
Helena Furberg1, Yunjung Kim1, Jennifer Dackor1, Eric Boerwinkle2, Nora Franceschini1, Diego Ardissino, Luisa Bernardinelli3, Luisa Bernardinelli4, Pier Mannuccio Mannucci5, Francesco Mauri, Piera Angelica Merlini, Devin Absher, Themistocles L. Assimes6, Stephen P. Fortmann6, Carlos Iribarren7, Joshua W. Knowles6, Thomas Quertermous6, Luigi Ferrucci8, Toshiko Tanaka8, Joshua C. Bis9, Curt D. Furberg10, Talin Haritunians11, Barbara McKnight9, Bruce M. Psaty12, Bruce M. Psaty9, Kent D. Taylor11, Evan L. Thacker9, Peter Almgren13, Leif Groop13, Claes Ladenvall13, Michael Boehnke14, Anne U. Jackson14, Karen L. Mohlke1, Heather M. Stringham14, Jaakko Tuomilehto15, Jaakko Tuomilehto16, Emelia J. Benjamin17, Shih-Jen Hwang8, Daniel Levy17, Sarah R. Preis8, Ramachandran S. Vasan17, Jubao Duan18, Pablo V. Gejman18, Douglas F. Levinson6, Alan R. Sanders18, Jianxin Shi8, Esther H. Lips19, James McKay19, Antonio Agudo, Luigi Barzan, Vladimir Bencko20, Simone Benhamou21, Simone Benhamou22, Xavier Castellsagué, Cristina Canova23, David I. Conway24, Eleonora Fabianova, Lenka Foretova, Vladimir Janout25, Claire M. Healy26, Ivana Holcatova20, Kristina Kjærheim, Pagona Lagiou27, Jolanta Lissowska, Ray Lowry28, Tatiana V. Macfarlane29, Dana Mates, Lorenzo Richiardi30, Peter Rudnai, Neonilia Szeszenia-Dabrowska31, David Zaridze32, Ariana Znaor, Mark Lathrop, Paul Brennan19, Stefania Bandinelli, Timothy M. Frayling33, Jack M. Guralnik8, Yuri Milaneschi, John R. B. Perry33, David Altshuler34, David Altshuler35, Roberto Elosua, S. Kathiresan35, S. Kathiresan34, Gavin Lucas, Olle Melander13, Christopher J. O'Donnell8, Veikko Salomaa16, Stephen M. Schwartz9, Benjamin F. Voight36, Brenda W.J.H. Penninx37, Johannes H. Smit37, Nicole Vogelzangs37, Dorret I. Boomsma37, Eco J. C. de Geus37, Jacqueline M. Vink37, Gonneke Willemsen37, Stephen J. Chanock8, Fangyi Gu34, Susan E. Hankinson34, David J. Hunter34, Albert Hofman38, Henning Tiemeier38, André G. Uitterlinden38, Cornelia M. van Duijn38, Stefan Walter38, Daniel I. Chasman34, Brendan M. Everett34, Guillaume Paré34, Paul M. Ridker34, Ming D. Li39, Hermine H. Maes40, Janet Audrain-McGovern41, Danielle Posthuma37, Laura M. Thornton1, Caryn Lerman41, Jaakko Kaprio16, Jaakko Kaprio15, Jed E. Rose42, John P. A. Ioannidis43, John P. A. Ioannidis44, Peter Kraft34, Danyu Lin1, Patrick F. Sullivan1 
TL;DR: A meta-analyses of several smoking phenotypes within cohorts of the Tobacco and Genetics Consortium found the strongest association was a synonymous 15q25 SNP in the nicotinic receptor gene CHRNA3, and three loci associated with number of cigarettes smoked per day were identified.
Abstract: Consistent but indirect evidence has implicated genetic factors in smoking behavior1,2. We report meta-analyses of several smoking phenotypes within cohorts of the Tobacco and Genetics Consortium (n = 74,053). We also partnered with the European Network of Genetic and Genomic Epidemiology (ENGAGE) and Oxford-GlaxoSmithKline (Ox-GSK) consortia to follow up the 15 most significant regions (n > 140,000). We identified three loci associated with number of cigarettes smoked per day. The strongest association was a synonymous 15q25 SNP in the nicotinic receptor gene CHRNA3 (rs1051730[A], b = 1.03, standard error (s.e.) = 0.053, beta = 2.8 x 10(-73)). Two 10q25 SNPs (rs1329650[G], b = 0.367, s. e. = 0.059, beta = 5.7 x 10(-10); and rs1028936[A], b = 0.446, s. e. = 0.074, beta = 1.3 x 10(-9)) and one 9q13 SNP in EGLN2 (rs3733829[G], b = 0.333, s. e. = 0.058, P = 1.0 x 10(-8)) also exceeded genome-wide significance for cigarettes per day. For smoking initiation, eight SNPs exceeded genome-wide significance, with the strongest association at a nonsynonymous SNP in BDNF on chromosome 11 (rs6265[C], odds ratio (OR) = 1.06, 95% confidence interval (Cl) 1.04-1.08, P = 1.8 x 10(-8)). One SNP located near DBH on chromosome 9 (rs3025343[G], OR = 1.12, 95% Cl 1.08-1.18, P = 3.6 x 10(-8)) was significantly associated with smoking cessation.

1,104 citations

Journal ArticleDOI
TL;DR: The classification of psoriasis; associated comorbidities including autoimmune diseases, cardiovascular risk, psychiatric/psychologic issues, and cancer risk; along with assessment tools for skin disease and quality-of-life issues; and the safety and efficacy of the biologic treatments used to treat patients with Psoriasis are discussed.
Abstract: Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In this first of 5 sections of the guidelines of care for psoriasis, we discuss the classification of psoriasis; associated comorbidities including autoimmune diseases, cardiovascular risk, psychiatric/psychologic issues, and cancer risk; along with assessment tools for skin disease and quality-of-life issues. Finally, we will discuss the safety and efficacy of the biologic treatments used to treat patients with psoriasis.

1,103 citations

Journal ArticleDOI
TL;DR: The authors found that board size and independence increase as firms grow and diversify over time; board size reflects a tradeoff between the firm-specific benefits and costs of monitoring; and board independence is negatively related to the manager's influence and positively related to constraints on that influence.

1,097 citations


Authors

Showing all 21721 results

NameH-indexPapersCitations
Salim Yusuf2311439252912
Ralph B. D'Agostino2261287229636
David J. Hunter2131836207050
Ronald Klein1941305149140
Luigi Ferrucci1931601181199
Bruce M. Psaty1811205138244
Kenneth C. Anderson1781138126072
Brenda W.J.H. Penninx1701139119082
Russel J. Reiter1691646121010
David R. Jacobs1651262113892
Barbara E.K. Klein16085693319
Christopher J. O'Donnell159869126278
Steven R. Cummings158579104007
David Cella1561258106402
Jack M. Guralnik14845383701
Network Information
Related Institutions (5)
University of Pittsburgh
201K papers, 9.6M citations

98% related

Duke University
200.3K papers, 10.7M citations

97% related

University of California, San Francisco
186.2K papers, 12M citations

96% related

University of North Carolina at Chapel Hill
185.3K papers, 9.9M citations

96% related

University of Pennsylvania
257.6K papers, 14.1M citations

96% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202365
2022343
20212,610
20202,331
20192,132
20181,978